StonvexLoading…
StonvexStonvexStonvexCore line items from INTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $64.38M | $58.14M | $57.61M | $47.22M |
Operating Income | $7.64M | $1.45M | $4.34M | $3.67M |
Net Income | $-5.35M | $-9.80M | $-6.72M | $-8.72M |
EPS (Diluted) | $-2.47 | $-4.40 | $-3.92 | $-3.92 |
Total Assets | $104.10M | $107.81M | $122.36M | $126.05M |
Total Liabilities | $218.41M | $214.28M | $216.96M | $209.05M |
Cash & Equivalents | $5.08M | $4.33M | $5.96M | $14.37M |
Free Cash Flow OCF − CapEx | $3.64M | $2.73M | $-5.97M | $-1.00M |
Shares Outstanding | 2.15M | 2.18M | 2.21M | 2.24M |